Recursion Pharmaceuticals, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2020 | $60.0K | $-18.3M | $-18.4M |
| Jun 2020 | $186.0K | $-18.2M | $-18.9M |
| Sep 2020 | $1.0M | $-22.5M | $-23.9M |
| Dec 2020 | $2.7M | $-25.6M | $-25.8M |
| Mar 2021 | $2.6M | $-30.5M | $-30.7M |
| Jun 2021 | $2.5M | $-40.9M | $-43.4M |
| Sep 2021 | $2.5M | $-46.4M | $-47.4M |
| Dec 2021 | $2.5M | $-65.0M | $-64.9M |
| Mar 2022 | $5.3M | $-56.0M | $-56.0M |
| Jun 2022 | $7.7M | $-66.2M | $-65.6M |
| Sep 2022 | $13.2M | $-62.6M | $-60.4M |
| Dec 2022 | $13.7M | $-61.0M | $-57.5M |
| Mar 2023 | $12.1M | $-69.9M | $-65.3M |
| Jun 2023 | $11.0M | $-81.7M | $-76.7M |
| Sep 2023 | $10.5M | $-99.6M | $-93.0M |
| Dec 2023 | $10.9M | $-98.9M | $-93.0M |
| Mar 2024 | $13.8M | $-96.3M | $-91.4M |
| Jun 2024 | $14.4M | $-100.5M | $-97.5M |
| Sep 2024 | $26.1M | $-98.4M | $-95.8M |
| Dec 2024 | $4.5M | $-183.8M | $-178.9M |
| Mar 2025 | $14.7M | $-191.4M | $-202.5M |
| Jun 2025 | $19.2M | $-176.2M | $-171.9M |
| Sep 2025 | $5.2M | $-172.2M | $-162.3M |
| Dec 2025 | $35.5M | $-108.3M | $-108.1M |
| Mar 2026 | $6.5M | $-128.5M | $-117.5M |
| Jun 2026 | $7.7M | $-135.0M | $-131.0M |